-
公开(公告)号:US20140017246A1
公开(公告)日:2014-01-16
申请号:US13959648
申请日:2013-08-05
申请人: Chung-Ming Hsieh , Margaret Hugunin , Anwar Murtaza , Bradford L. McRae , Yuliya Kutskova , John E. Memmott , Jennifer M. Perez , Suju Zhong , Edit Tarcsa , Anca Clabbers , Craig Wallace , Shaughn H. Bryant , Mary R. Leddy
发明人: Chung-Ming Hsieh , Margaret Hugunin , Anwar Murtaza , Bradford L. McRae , Yuliya Kutskova , John E. Memmott , Jennifer M. Perez , Suju Zhong , Edit Tarcsa , Anca Clabbers , Craig Wallace , Shaughn H. Bryant , Mary R. Leddy
IPC分类号: C07K16/24
CPC分类号: C07K16/468 , A61K39/3955 , A61K2039/505 , A61K2039/507 , A61K2300/00 , C07K16/241 , C07K16/244 , C07K2317/21 , C07K2317/31 , C07K2317/50 , C07K2317/565 , C07K2317/64 , C07K2317/76 , C07K2317/92 , Y02A50/386 , Y02A50/41 , Y02A50/412 , Y02A50/466
摘要: Proteins that bind IL-17 and/or IL-17F are described along with there use in composition and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions.
-
公开(公告)号:US08623358B2
公开(公告)日:2014-01-07
申请号:US12870276
申请日:2010-08-27
申请人: Lorenzo Benatuil , Erwin R. Boghaert , Jijie Gu , Maria Harris , Jonathan A. Hickson , Chung-Ming Hsieh , Yuliya Kutskova , Yingchun Li , Zhihong Liu , Susan Morgan-Lappe
发明人: Lorenzo Benatuil , Erwin R. Boghaert , Jijie Gu , Maria Harris , Jonathan A. Hickson , Chung-Ming Hsieh , Yuliya Kutskova , Yingchun Li , Zhihong Liu , Susan Morgan-Lappe
IPC分类号: A61K39/395
CPC分类号: C07K16/22 , A61K39/3955 , A61K45/06 , A61K2039/505 , C07K7/06 , C07K7/08 , C07K14/47 , C07K16/18 , C07K2317/21 , C07K2317/33 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: Improved DLL4 binding proteins are described, including antibodies, CDR-grafted antibodies, human antibodies, and DLL4 binding fragments thereof, proteins that bind DLL4 with high affinity, and DLL4 binding proteins that neutralize DLL4 activity. The DLL4 binding proteins are useful for treating or preventing cancers and tumors and especially for treating or preventing tumor angiogenesis, and/or other angiogenesis-dependent diseases such as ocular neovascularization, or angiogenesis-independent diseases characterized by aberrant DLL4 expression or activity such as autoimmune disorders including multiple sclerosis.
摘要翻译: 描述了改进的DLL4结合蛋白,包括抗体,CDR-移植抗体,人抗体和DLL4结合片段,以高亲和力结合DLL4的蛋白质,以及中和DLL4活性的DLL4结合蛋白。 DLL4结合蛋白可用于治疗或预防癌症和肿瘤,特别是用于治疗或预防肿瘤血管生成和/或其它血管发生依赖性疾病,例如眼新生血管形成或以异常DLL4表达或活性为特征的血管发生非依赖性疾病,例如自身免疫 包括多发性硬化的疾病。
-
公开(公告)号:US20120091976A1
公开(公告)日:2012-04-19
申请号:US12954670
申请日:2010-11-25
申请人: Chi-Ming Chen , Chung-Ming Hsieh
发明人: Chi-Ming Chen , Chung-Ming Hsieh
IPC分类号: G05F1/00
CPC分类号: H03K17/687 , H03K17/302 , H03K2017/307 , H03K2217/0063 , H03K2217/0081
摘要: A bootstrap circuit without a regulator and a diode includes a comparator, a first switch, and a capacitor. The comparator has a first terminal for receiving a reference voltage, a second terminal coupled to a bootstrap voltage output terminal of the bootstrap circuit, and a third terminal for outputting a switch control signal. The first switch has a first terminal for receiving an input voltage, a second terminal for receiving the switch control signal, and a third terminal coupled to the bootstrap voltage output terminal. The capacitor is coupled between a voltage switching terminal and the second terminal of the comparator.
摘要翻译: 没有调节器和二极管的自举电路包括比较器,第一开关和电容器。 比较器具有用于接收参考电压的第一端子,耦合到自举电路的自举电压输出端的第二端子和用于输出开关控制信号的第三端子。 第一开关具有用于接收输入电压的第一端子,用于接收开关控制信号的第二端子和耦合到自举电压输出端子的第三端子。 电容器耦合在电压开关端子和比较器的第二端子之间。
-
公开(公告)号:US20110223176A1
公开(公告)日:2011-09-15
申请号:US13042650
申请日:2011-03-08
申请人: Eve H. Barlow , Chung-Ming Hsieh , Denise D. Karaoglu Hanzatian , Gillian Ann Kingsbury , Susan E. Morgan-Lappe , Edward B. Reilly , Fritz G. Buchanan , Yingchun Li
发明人: Eve H. Barlow , Chung-Ming Hsieh , Denise D. Karaoglu Hanzatian , Gillian Ann Kingsbury , Susan E. Morgan-Lappe , Edward B. Reilly , Fritz G. Buchanan , Yingchun Li
IPC分类号: A61K39/395 , C07K16/28 , C07K16/46 , C07H21/04 , C12N15/63 , C12N5/16 , C12N5/22 , A61P35/00 , G01N33/574
CPC分类号: C07K16/2803 , A61K2039/505 , C07K2317/24 , C07K2317/565 , C07K2317/73 , C07K2317/732 , C07K2317/734 , C07K2317/92
摘要: Isolated binding proteins, e.g., antibodies, which bind to Basigin (BSG), e.g., human BSG2, and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antibodies.
摘要翻译: 公开了分离的结合蛋白,例如结合Basigin(BSG)的抗体,例如人BSG2,以及相关的基于抗体的组合物和分子。 还公开了包含抗体的药物组合物,以及使用抗体的治疗和诊断方法。
-
25.
公开(公告)号:US5846773A
公开(公告)日:1998-12-08
申请号:US795868
申请日:1997-02-06
申请人: Mu-En Lee , Chung-Ming Hsieh
发明人: Mu-En Lee , Chung-Ming Hsieh
IPC分类号: C12N15/09 , A61K38/00 , A61K48/00 , C07K14/47 , C12N5/10 , C12N15/12 , C12P21/02 , C07H21/04 , C12N15/11 , C12N15/85
CPC分类号: C07K14/47 , C07K14/4716 , A61K38/00 , A61K48/00
摘要: Aortic-preferentially-expressed gene-1 (APEG-1) and striated muscle preferentially expressed (SPEG) polypeptide, DNA sequences encoding and controlling the transcription of the APEG-1/SPEG encoding gene, methods of diagnosing vascular injury, methods of conferring smooth muscle-cell specific expression, and methods of inhibiting vascular smooth muscle cell proliferation by increasing the level of APEG-1 at the site of vascular injury.
-
公开(公告)号:US09115195B2
公开(公告)日:2015-08-25
申请号:US13037932
申请日:2011-03-01
CPC分类号: C07K16/28 , A61K39/3955 , A61K45/06 , A61K2039/505 , C07K2317/24 , C07K2317/73 , C07K2317/76 , C07K2317/92
摘要: DLL4 binding proteins are described herein, including antibodies, CDR-grafted antibodies, humanized antibodies, and DLL4 binding fragments thereof, proteins that bind DLL4 with high affinity, and DLL4 binding proteins that neutralize DLL4 and/or VEGF activity. The DLL4 binding proteins are useful for treating or preventing cancers and tumors and especially for treating or preventing tumor angiogenesis.
摘要翻译: 本文描述了DLL4结合蛋白,包括抗体,CDR-移植抗体,人源化抗体及其DLL4结合片段,以高亲和力结合DLL4的蛋白质,以及中和DLL4和/或VEGF活性的DLL4结合蛋白。 DLL4结合蛋白可用于治疗或预防癌症和肿瘤,特别是用于治疗或预防肿瘤血管生成。
-
公开(公告)号:US08999331B2
公开(公告)日:2015-04-07
申请号:US13659647
申请日:2012-10-24
申请人: Chung-Ming Hsieh , Alexander Ivanov , Wendy Waegell , Yuliya Kutskova , John Memmott , Lorenzo Benatuil , Jacqueline Bixby , Emma Fung , Sahana Bose , Alyssa Brito
发明人: Chung-Ming Hsieh , Alexander Ivanov , Wendy Waegell , Yuliya Kutskova , John Memmott , Lorenzo Benatuil , Jacqueline Bixby , Emma Fung , Sahana Bose , Alyssa Brito
IPC分类号: A61K39/00 , A61K39/395 , C07K16/00 , C07K16/18 , C07K16/22 , C07K16/24 , A61K31/353 , A61K31/439 , A61K31/44 , A61K31/4439 , A61K31/519 , A61K31/56 , A61K38/13 , A61K38/17 , A61K38/18 , A61K38/19 , A61K38/20 , A61K38/21
CPC分类号: C07K16/468 , A61K31/353 , A61K31/439 , A61K31/44 , A61K31/4439 , A61K31/519 , A61K31/56 , A61K38/13 , A61K38/1793 , A61K38/18 , A61K38/1808 , A61K38/1816 , A61K38/19 , A61K38/191 , A61K38/2026 , A61K38/2066 , A61K38/2073 , A61K38/217 , A61K39/3955 , A61K2039/505 , C07K16/18 , C07K16/22 , C07K16/241 , C07K2317/21 , C07K2317/31 , C07K2317/565 , C07K2317/60 , C07K2317/64 , C07K2317/76 , C07K2317/90 , C07K2317/92 , C07K2317/94
摘要: Proteins that bind sclerostin or sclerostin and TNF are described along with there use in composition and methods for treating, preventing, and diagnosing sclerostin related diseases and for detecting sclerostin or sclerostin and TNF in cells, tissues, samples, and compositions.
摘要翻译: 与用于治疗,预防和诊断硬化性相关疾病的组合物和方法一起描述了结合硬化蛋白或硬化性骨肉瘤和TNF的蛋白质,并用于检测细胞,组织,样品和组合物中的硬化蛋白或硬化性骨肉瘤和TNF。
-
公开(公告)号:US20140335564A1
公开(公告)日:2014-11-13
申请号:US14258994
申请日:2014-04-22
申请人: Chung-Ming Hsieh , Margaret Hugunin , Anwar Murtaza , Bradford L. McRae , Yuliya Kutskova , John E. Memmott , Jennifer M. Perez , Suju Zhong , Edit Tarcsa , Anca Clabbers , Craig Wallace , Shaughn H. Bryant , Mary R. Leddy
发明人: Chung-Ming Hsieh , Margaret Hugunin , Anwar Murtaza , Bradford L. McRae , Yuliya Kutskova , John E. Memmott , Jennifer M. Perez , Suju Zhong , Edit Tarcsa , Anca Clabbers , Craig Wallace , Shaughn H. Bryant , Mary R. Leddy
IPC分类号: C07K16/24
CPC分类号: C07K16/468 , A61K39/3955 , A61K2039/505 , A61K2039/507 , A61K2300/00 , C07K16/241 , C07K16/244 , C07K2317/21 , C07K2317/31 , C07K2317/50 , C07K2317/565 , C07K2317/64 , C07K2317/76 , C07K2317/92 , Y02A50/386 , Y02A50/41 , Y02A50/412 , Y02A50/466
摘要: Proteins that bind IL-17 and/or IL-17F are described along with there use in composition and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions.
-
公开(公告)号:US08455219B2
公开(公告)日:2013-06-04
申请号:US13368618
申请日:2012-02-08
申请人: Chung-Ming Hsieh
发明人: Chung-Ming Hsieh
IPC分类号: C07K16/324 , C07K2316/52 , C07K2316/96 , C07K2317/21
CPC分类号: C12P21/00 , C07K16/241 , C07K2317/21 , C07K2317/52
摘要: The present invention features nucleic acids for recombinant protein expression in mammalian cell culture. The episomal vectors of the invention promote high protein production in mammalian cells expressing the SV40 T Ag or Epstein-Barr virus nuclear antigen (e.g., COS7 or HEK293-6E cells). The methods and systems are useful, for example, in pharmaceutical drug development and cloning, especially for the production of antibodies.
摘要翻译: 本发明的特征在于哺乳动物细胞培养中用于重组蛋白表达的核酸。 本发明的附加型载体在表达SV40T Ag或爱泼斯坦 - 巴尔病毒核抗原(例如COS7或HEK293-6E细胞)的哺乳动物细胞中促进高蛋白质产生。 所述方法和系统在例如药物开发和克隆中尤为有利于制备抗体。
-
公开(公告)号:US08404445B2
公开(公告)日:2013-03-26
申请号:US12570897
申请日:2009-09-30
CPC分类号: C40B50/06 , C07K16/00 , C07K16/1018 , C07K16/241 , C07K16/244 , C07K2317/21 , C07K2317/622 , C12Q2563/185 , C40B40/08
摘要: The present invention features improved in vitro RNA display libraries to allow reliable expression and selection of scFv antibody molecules from expression libraries. The scFv antibody libraries of the invention contain an optimized, shortened inter-domain linker that improves expression scFv antibody expression. The scFv antibody libraries also include short nucleic acid barcodes that allow for identification of individual library clones, libraries or subsets thereof. Primers for generating, amplifying and spectratyping the scFv antibody libraries of the invention are also provided.
摘要翻译: 本发明的特征在于改进的体外RNA显示文库以允许来自表达文库的scFv抗体分子的可靠表达和选择。 本发明的scFv抗体文库含有改善表达scFv抗体表达的优化的,缩短的域间连接体。 scFv抗体文库还包括允许识别单个文库克隆,文库或其子集的短核酸条形码。 还提供了用于产生,扩增和分光本发明的scFv抗体文库的引物。
-
-
-
-
-
-
-
-
-